Burkhard Prause, President and CEO of Bruker BeST, filed a Form 4 on August 18, 2026, disclosing the acquisition of restricted stock units and stock options in Bruker Corporation common stock on August 15, 2026.

Key Highlights

  • RSU Grant: Burkhard Prause acquired 3,303 restricted stock units in Bruker Corporation common stock at a price of $0 on August 15, 2026.
  • Post-Transaction Ownership: Following the RSU grant, Prause directly holds 28,461 shares of common stock.
  • Stock Option Grant: Prause also acquired 2,678 stock options with an exercise price of $57.70, granted on August 15, 2026.
  • Vesting Schedule: Both the RSUs and stock options vest in equal installments on the first, second, third, and fourth anniversaries of August 15, 2026.
  • Option Expiration: The stock options are exercisable beginning August 15, 2027, and expire on August 15, 2036.

Bruker BeST President and CEO Granted Equity Awards in August 2026

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Burkhard Prause, who holds the title of President and CEO of Bruker BeST and is an officer of Bruker Corporation (NASDAQ:BRKR), received two equity grants on August 15, 2026. The filing reports that Prause acquired 3,303 restricted stock units in Bruker Corporation common stock at no cost. Following this transaction, the filing states that Prause directly beneficially owns 28,461 shares of common stock.

In addition to the RSU grant, the filing discloses that Prause acquired 2,678 stock options, carrying an exercise price of $57.70 per share. The options were granted on August 15, 2026, with exercisability beginning August 15, 2027, and an expiration date of August 15, 2036. The price of the derivative security is listed as $0. Both the RSUs and the stock options were acquired with transaction code "A," indicating an acquisition. The filing notes that both grants vest in equal installments on the first, second, third, and fourth anniversaries of the original grant date. All holdings reported are held directly by Prause.

The Form 4 was signed by Michael Simone as attorney-in-fact on behalf of Prause and filed on August 18, 2026. The date of earliest transaction is listed as August 15, 2026.

What Was Disclosed

Burkhard Prause, an officer of Bruker Corporation serving as President and CEO of Bruker BeST, reported receiving 3,303 RSUs and 2,678 stock options in Bruker common stock, both granted on August 15, 2026, with four-year ratable vesting schedules.